Otto ^Beta

STAT+: A setback for Roche’s breast cancer drug

STAT+: Health tech company says it will dive into Medicare’s new chronic care experiment

STAT+: 5 lessons from Vinay Prasad’s turbulent tenure at the FDA

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

Federal autism advisory board cancels first public meeting since overhaul